Hi all,
I'm relatively new to investing, but I've been lurking here for a while and have appreciated the insight and debate while tyring to perform some due dilligence. The first forum I found (Stockouse) was full of bashers, pumpers and personal attacks and it was hard to tease out any relevant information.
Anyway, Zen's segmentation of the four target markets is very specific. We have confirmation that our grapite is in the hands of end users who are successfully using it in lithium ion battery, fuel cell, and powder metallurgy applications albeit in preliminary testing. What are the odds that the reason for this is a series off offtake agreements contingent on final testing of the product? It sure would be nice to get news off 4 offtake agreements post PEA!
Cheers and GLTA
